CN106858586A - 一种防治心脑血管疾病的地龙蛋白纳豆人参复合蛋白产品 - Google Patents
一种防治心脑血管疾病的地龙蛋白纳豆人参复合蛋白产品 Download PDFInfo
- Publication number
- CN106858586A CN106858586A CN201710026857.4A CN201710026857A CN106858586A CN 106858586 A CN106858586 A CN 106858586A CN 201710026857 A CN201710026857 A CN 201710026857A CN 106858586 A CN106858586 A CN 106858586A
- Authority
- CN
- China
- Prior art keywords
- powder
- parts
- natto
- cerebrovascular disease
- preventing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013557 nattō Nutrition 0.000 title claims abstract description 15
- 102000004169 proteins and genes Human genes 0.000 title claims abstract description 15
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 15
- 241000208340 Araliaceae Species 0.000 title claims abstract description 13
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 title claims abstract description 13
- 235000003140 Panax quinquefolius Nutrition 0.000 title claims abstract description 13
- 208000026106 cerebrovascular disease Diseases 0.000 title claims abstract description 13
- 230000002526 effect on cardiovascular system Effects 0.000 title claims abstract description 13
- 235000008434 ginseng Nutrition 0.000 title claims abstract description 13
- 208000024172 Cardiovascular disease Diseases 0.000 title claims abstract description 12
- 150000001875 compounds Chemical class 0.000 title claims abstract description 7
- 239000000843 powder Substances 0.000 claims abstract description 41
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 8
- 241000195493 Cryptophyta Species 0.000 claims abstract description 6
- 244000068988 Glycine max Species 0.000 claims abstract description 6
- 235000010469 Glycine max Nutrition 0.000 claims abstract description 6
- 244000046146 Pueraria lobata Species 0.000 claims abstract description 6
- 235000010575 Pueraria lobata Nutrition 0.000 claims abstract description 6
- 150000003904 phospholipids Chemical class 0.000 claims abstract description 6
- 150000003839 salts Chemical class 0.000 claims abstract description 6
- 240000008620 Fagopyrum esculentum Species 0.000 claims abstract description 5
- 235000009419 Fagopyrum esculentum Nutrition 0.000 claims abstract description 5
- 241000228347 Monascus <ascomycete fungus> Species 0.000 claims abstract description 5
- 235000021388 linseed oil Nutrition 0.000 claims abstract description 5
- 239000000944 linseed oil Substances 0.000 claims abstract description 5
- 239000003094 microcapsule Substances 0.000 claims abstract description 5
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims abstract description 4
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims abstract description 4
- 235000009685 Crataegus X maligna Nutrition 0.000 claims abstract description 4
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims abstract description 4
- 235000009486 Crataegus bullatus Nutrition 0.000 claims abstract description 4
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims abstract description 4
- 235000009682 Crataegus limnophila Nutrition 0.000 claims abstract description 4
- 240000000171 Crataegus monogyna Species 0.000 claims abstract description 4
- 235000004423 Crataegus monogyna Nutrition 0.000 claims abstract description 4
- 235000002313 Crataegus paludosa Nutrition 0.000 claims abstract description 4
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims abstract description 4
- 241000361919 Metaphire sieboldi Species 0.000 claims abstract description 4
- 230000009286 beneficial effect Effects 0.000 abstract description 3
- 108010073771 Soybean Proteins Proteins 0.000 abstract description 2
- 241000411851 herbal medicine Species 0.000 abstract description 2
- 235000016709 nutrition Nutrition 0.000 abstract 1
- 230000035764 nutrition Effects 0.000 abstract 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 18
- 210000004369 blood Anatomy 0.000 description 14
- 239000008280 blood Substances 0.000 description 14
- 235000012000 cholesterol Nutrition 0.000 description 9
- 201000001320 Atherosclerosis Diseases 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 230000017531 blood circulation Effects 0.000 description 4
- 210000004204 blood vessel Anatomy 0.000 description 4
- 150000002632 lipids Chemical class 0.000 description 4
- 206010020772 Hypertension Diseases 0.000 description 3
- 102000007330 LDL Lipoproteins Human genes 0.000 description 3
- 108010007622 LDL Lipoproteins Proteins 0.000 description 3
- 208000007536 Thrombosis Diseases 0.000 description 3
- 210000001367 artery Anatomy 0.000 description 3
- 208000029078 coronary artery disease Diseases 0.000 description 3
- 230000002107 myocardial effect Effects 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 244000063299 Bacillus subtilis Species 0.000 description 2
- 235000014469 Bacillus subtilis Nutrition 0.000 description 2
- 102000015779 HDL Lipoproteins Human genes 0.000 description 2
- 108010010234 HDL Lipoproteins Proteins 0.000 description 2
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 description 2
- 241000219780 Pueraria Species 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 210000004351 coronary vessel Anatomy 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 210000002889 endothelial cell Anatomy 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000004217 heart function Effects 0.000 description 2
- 239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 229940086319 nattokinase Drugs 0.000 description 2
- 108010073682 nattokinase Proteins 0.000 description 2
- 230000036284 oxygen consumption Effects 0.000 description 2
- 210000002381 plasma Anatomy 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical group CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- PFRQBZFETXBLTP-RCIYGOBDSA-N 2-[(2e,6e,10e,14e,18e)-3,7,11,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaen-1-yl]-3-methyl-1,4-dihydronaphthalene-1,4-dione Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CC/C=C(C)/CC/C=C(C)/CC/C=C(C)/CC/C=C(C)/CCC=C(C)C)=C(C)C(=O)C2=C1 PFRQBZFETXBLTP-RCIYGOBDSA-N 0.000 description 1
- BWWAFUZQSLIIIH-UHFFFAOYSA-N 2-phenyl-3H-chromen-3-id-4-one Chemical compound O1C(=[C-]C(=O)C2=CC=CC=C12)C1=CC=CC=C1 BWWAFUZQSLIIIH-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 208000035150 Hypercholesterolemia Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- 206010054949 Metaplasia Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 description 1
- 102000019197 Superoxide Dismutase Human genes 0.000 description 1
- 108010012715 Superoxide dismutase Proteins 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 230000001147 anti-toxic effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000002457 bidirectional effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 230000005961 cardioprotection Effects 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 210000003038 endothelium Anatomy 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000000055 hyoplipidemic effect Effects 0.000 description 1
- 208000021822 hypotensive Diseases 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- LVPMIMZXDYBCDF-UHFFFAOYSA-N isocinchomeronic acid Chemical compound OC(=O)C1=CC=C(C(O)=O)N=C1 LVPMIMZXDYBCDF-UHFFFAOYSA-N 0.000 description 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 1
- 150000002515 isoflavone derivatives Chemical class 0.000 description 1
- 235000008696 isoflavones Nutrition 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 150000002617 leukotrienes Chemical class 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000015689 metaplastic ossification Effects 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000009862 primary prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 description 1
- GJAWHXHKYYXBSV-UHFFFAOYSA-N pyridinedicarboxylic acid Natural products OC(=O)C1=CC=CN=C1C(O)=O GJAWHXHKYYXBSV-UHFFFAOYSA-N 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 229940026314 red yeast rice Drugs 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 230000009863 secondary prevention Effects 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 229940083466 soybean lecithin Drugs 0.000 description 1
- 239000008347 soybean phospholipid Substances 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 239000003071 vasodilator agent Substances 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/02—Algae
- A61K36/05—Chlorophycota or chlorophyta (green algae), e.g. Chlorella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
本发明公开一种防治心脑血管疾病的地龙蛋白纳豆人参复合蛋白产品，其含有人参粉、葛根粉、纳豆粉、红曲红、山楂粉、白背三七粉、粉末磷脂、荞麦粉、亚麻籽油微囊粉、地龙蛋白粉、盐藻粉、大豆肽。本发明采用地龙蛋白、大豆肽与中草药中的天然成分配伍使用，补足营养，有益防治心脑血管疾病。
Description
技术领域
本发明涉及一种复合产品，尤其是涉及一种防治心脑血管疾病的地龙蛋白纳豆人参复合蛋白产品。
背景技术
心血管疾病，以冠心病为主，冠心病又称为冠状动脉硬化性心脏病，由于供应心肌血液的冠状动脉发生粥样硬化，导致动脉血管变窄，心肌供血不足而发病。心血管疾病存在一个共同的病理改变，涉及动脉粥样硬化和血栓形成。高血压和高脂血是动脉粥样硬化的重要危险因素。因此，防治心脑血管疾病要从两方面入手，一要控制血压、血脂，避免高血压、高血脂；二要保护心脏，改善心脏功能。
发明内容
本发明的目的是提供了一种包含地龙蛋白、大豆肽、中草药有效成分等的复合产品，可以起到防治心脑血管疾病的作用。
本发明是以如下技术方案实现的：一种防治心脑血管疾病的地龙蛋白纳豆人参复合蛋白产品含有人参粉8-12份、葛根粉10-30份、纳豆粉20-50份、红曲红50-100份、山楂粉30-60份、白背三七粉10-30份、粉末磷脂5-15份、荞麦粉150-200份、亚麻籽油微囊粉30-70份、地龙蛋白粉1-4份、盐藻粉1-5份、大豆肽30-60份。
人参味甘微苦，生用微凉，熟用微温。具有大补元气，养阴生津，宁心安神等功效，既可补气又能养阴，适用于扶正祛邪。
葛根有扩张心脑血管,改善血循环,促进血运,增加心脑血流量,改善缺血缺氧,葛根有活血化瘀通脉,缓解血管痉挛作用。葛根素是一种新型的血管扩张药,它对冠状动脉和脑血管有扩张作用,降低心肌耗氧量,并有活血化淤,改善缺血区的微循环,改善高粘滞血症、高凝血症的作用。葛根总黄酮能降低心肌耗氧量,增加氧供应。
纳豆是纳豆菌将小粒黄豆分解后的产物。纳豆中富含纳豆菌、优质小分子蛋白质（肽）、纳豆激酶、超氧化物歧化酶、生物多糖、异黄酮、皂甙、卵磷脂、维生素E、吡啶二羧酸、维生素K2等几十种对人体有益的活性物质。纳豆含有的纳豆激酶,可排除体内胆固醇、分解体内酸化型脂质,使异常血压恢复正常。
红曲含有天然的他汀类药物成份，他汀类药物是临床上常用的降血脂的药物。红曲可以综合调节血脂，实现“三降一升”，即降低胆固醇、甘油三脂、低密度脂蛋白，升高高密度脂蛋白，清除血管垃圾，保护血管内皮，一级预防和二级预防各类心脑血管疾病，如脑中风、冠心病、高血压、心肌梗死等。
山楂除了具有降血脂降血压的功能，还能有效改善心脏功能。除了能够降低对人体有害的低密度脂蛋白含量，防止低密度脂蛋白透过内皮细胞深入内皮细胞间隙，减少动脉内壁脂质的形成，还能够升高高密度脂蛋白含量，及时消除血管内壁形成的垃圾、毒素和斑块，达到真正的双向调节血脂和防止动脉粥样硬化的作用。
大豆磷脂磷脂为天然降血脂药，具有显著的抗氧化、降血脂作用。它是清除人体内胆固醇、甘油三醋过程中起重要作用的高密度脂蛋白的基本成分，可维持胆固醇醋酶活性，在血浆内起乳化剂作用，影响体内脂肪的吸收和利用，减少血中胆固醇含量，洗刷血管内壁的沉着物，可预防或减轻动脉粥样硬化和脑血管障碍。大豆磷脂具有一定的防止胆固醇在血管壁沉积作用，适用于轻度高脂血症和防治动脉粥样硬化。此外，磷脂可参与脂肪和胆固醇的运输，血浆中磷脂过低，则胆固醇/卵磷脂比例增大，易出现胆固醇沉积而引起动脉粥样硬化，因此磷脂有抗高胆固醇血症的作用，可用于防治高胆固醇血症和动脉粥样硬化。
盐藻含丰富的碱性矿物质（尤其是钾与钙质），可维持血液中酸碱值的平衡，降低胆固醇，减轻高血压和心脏病症状或减少其发病几率；含有人体自身不能合成的亚麻酸，帮助脂肪代谢，防止血栓形成，有效对抗心脑血管疾病。
本发明的有益效果是：本发明将现代营养学研究成果与传统养生保健理论相结合，研制出了一种防治心脑血管疾病的地龙蛋白纳豆人参复合蛋白产品。通过各种配料的有机组合，将各种功能进行融合，并通过有效成分之间的协同作用，增强作用效果。且口感良好、风味独特。工艺简单，易操作，适宜工厂规模化生产。
具体实施方式
下面结合实施例对本发明做进一步描述。
实施例1
本实施例的组分及重量份数为：人参粉9份、葛根粉16份、纳豆粉24份、红曲红60份、山楂粉40份、白背三七粉16份、粉末磷脂6份、荞麦粉170份、亚麻籽油微囊粉50份、地龙蛋白粉2份、盐藻粉1-54份、大豆肽50份。
将上述原料混合，搅拌均匀，经过干燥，制成粉状食品。用一定量温开水冲调后，可直接食用。
实施例2
本实施例的组分及重量份数为：人参粉10份、葛根粉20份、纳豆粉45份、红曲红60份、山楂粉36份、白背三七粉18份、粉末磷脂12份、荞麦粉180份、亚麻籽油微囊粉50份、地龙蛋白粉3份、盐藻粉2份、大豆肽40份。
将上述原料混合，搅拌均匀，经过干燥，制成粉状食品。用一定量温开水冲调后，可直接食用。
以上对本发明进行了详细介绍，以上实施例的说明只是用于帮助理解本发明。本领域的普通技术人员应当理解，可以对本发明的技术方案进行更动、润饰或者等同替换，而不脱离本发明技术方案的精神和范围，其均应属于本发明的权利要求保护范围当中。
Claims (1)
1.一种防治心脑血管疾病的地龙蛋白纳豆人参复合蛋白产品，其特征在于它含有人参粉8-12份、葛根粉10-30份、纳豆粉20-50份、红曲红50-100份、山楂粉30-60份、白背三七粉10-30份、粉末磷脂5-15份、荞麦粉150-200份、亚麻籽油微囊粉30-70份、地龙蛋白粉1-4份、盐藻粉1-5份、大豆肽30-60份。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710026857.4A CN106858586A (zh) | 2017-01-14 | 2017-01-14 | 一种防治心脑血管疾病的地龙蛋白纳豆人参复合蛋白产品 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710026857.4A CN106858586A (zh) | 2017-01-14 | 2017-01-14 | 一种防治心脑血管疾病的地龙蛋白纳豆人参复合蛋白产品 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106858586A true CN106858586A (zh) | 2017-06-20 |
Family
ID=59158064
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710026857.4A Pending CN106858586A (zh) | 2017-01-14 | 2017-01-14 | 一种防治心脑血管疾病的地龙蛋白纳豆人参复合蛋白产品 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106858586A (zh) |
Cited By (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107692195A (zh) * | 2017-07-24 | 2018-02-16 | 哈尔滨工业大学 | 一套适用于脑中风病人鼻饲的间餐营养餐包及其制备方法 |
| CN107982513A (zh) * | 2017-11-29 | 2018-05-04 | 北京艾沃森科技有限公司 | 一种盐藻地龙蛋白复方保健品及其制备方法 |
| CN108902430A (zh) * | 2018-06-25 | 2018-11-30 | 丁红卫 | 一种辅助调理心脑血管疾病组合保健品 |
| CN109077313A (zh) * | 2018-09-19 | 2018-12-25 | 吉林省恒实传食品科技发展有限公司 | 一种降血脂预防心脑血管疾病的健康养生食品及其制备方法 |
| CN109090597A (zh) * | 2018-07-09 | 2018-12-28 | 杭州纤唯康生物科技有限公司 | 一种辅助降三高组合物及其制备方法和应用 |
| CN109645464A (zh) * | 2019-01-10 | 2019-04-19 | 蕴彤本草(北京)生物科技有限公司 | 具有活血降脂溶栓和中风康复效果复合营养素及制备方法 |
| CN109663069A (zh) * | 2018-12-21 | 2019-04-23 | 上海胡庆余堂健康产业有限公司 | 一种疏通血管、保护心脑的复方制剂、制备方法及制备装置 |
| CN109892599A (zh) * | 2019-04-15 | 2019-06-18 | 吉林省九圣源生物科技有限公司 | 一种供冠心病人群食用的药膳 |
| CN110089758A (zh) * | 2019-05-07 | 2019-08-06 | 朱国强 | 一种含活性地龙蛋白纳豆激酶复合多酶食品及其制备方法 |
| CN110089760A (zh) * | 2019-05-07 | 2019-08-06 | 朱国强 | 一种含活性地龙蛋白纳豆激酶复合多酶食品的加工工艺 |
| CN110089759A (zh) * | 2019-05-07 | 2019-08-06 | 朱国强 | 一种适用于心脑血管疾病患者食用的复合多酶食品 |
| CN110250524A (zh) * | 2019-07-31 | 2019-09-20 | 无棣珍康生物科技有限公司 | 一种地龙蛋白复合片及其制备方法 |
| CN110679951A (zh) * | 2019-11-13 | 2020-01-14 | 江西沐恩堂生物科技有限公司 | 一种食用地龙蛋白营养产品 |
| CN110680874A (zh) * | 2019-09-25 | 2020-01-14 | 王运权 | 一种治疗心脑血管疾病的中药 |
| CN111357858A (zh) * | 2019-09-18 | 2020-07-03 | 广州市好孝心医疗器械有限公司 | 一种具有溶血栓和软化血管功能的复合多肽地龙蛋白压片糖果及其制备方法 |
| CN111418851A (zh) * | 2020-04-29 | 2020-07-17 | 私诺(北京)健康科技有限公司 | 一种血管养护的营养食品 |
| CN112790375A (zh) * | 2020-12-02 | 2021-05-14 | 金口健康管理(潍坊)有限公司 | 一种用于心脑血管疾病的药食同源配方及制备方法 |
| CN115299596A (zh) * | 2021-11-10 | 2022-11-08 | 山东安然纳米实业发展有限公司 | 一种包含人参干细胞的辅助降血脂组合物及其应用 |
| CN117297096A (zh) * | 2023-11-29 | 2023-12-29 | 吉林省特医食品生物科技有限公司 | 一种针对心脑血管的药食同源组合物及制备方法 |
-
2017
- 2017-01-14 CN CN201710026857.4A patent/CN106858586A/zh active Pending
Cited By (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107692195A (zh) * | 2017-07-24 | 2018-02-16 | 哈尔滨工业大学 | 一套适用于脑中风病人鼻饲的间餐营养餐包及其制备方法 |
| CN107982513A (zh) * | 2017-11-29 | 2018-05-04 | 北京艾沃森科技有限公司 | 一种盐藻地龙蛋白复方保健品及其制备方法 |
| CN108902430A (zh) * | 2018-06-25 | 2018-11-30 | 丁红卫 | 一种辅助调理心脑血管疾病组合保健品 |
| CN109090597A (zh) * | 2018-07-09 | 2018-12-28 | 杭州纤唯康生物科技有限公司 | 一种辅助降三高组合物及其制备方法和应用 |
| CN109077313A (zh) * | 2018-09-19 | 2018-12-25 | 吉林省恒实传食品科技发展有限公司 | 一种降血脂预防心脑血管疾病的健康养生食品及其制备方法 |
| CN109663069A (zh) * | 2018-12-21 | 2019-04-23 | 上海胡庆余堂健康产业有限公司 | 一种疏通血管、保护心脑的复方制剂、制备方法及制备装置 |
| CN109645464A (zh) * | 2019-01-10 | 2019-04-19 | 蕴彤本草(北京)生物科技有限公司 | 具有活血降脂溶栓和中风康复效果复合营养素及制备方法 |
| CN109892599A (zh) * | 2019-04-15 | 2019-06-18 | 吉林省九圣源生物科技有限公司 | 一种供冠心病人群食用的药膳 |
| CN110089758A (zh) * | 2019-05-07 | 2019-08-06 | 朱国强 | 一种含活性地龙蛋白纳豆激酶复合多酶食品及其制备方法 |
| CN110089760A (zh) * | 2019-05-07 | 2019-08-06 | 朱国强 | 一种含活性地龙蛋白纳豆激酶复合多酶食品的加工工艺 |
| CN110089759A (zh) * | 2019-05-07 | 2019-08-06 | 朱国强 | 一种适用于心脑血管疾病患者食用的复合多酶食品 |
| CN110250524A (zh) * | 2019-07-31 | 2019-09-20 | 无棣珍康生物科技有限公司 | 一种地龙蛋白复合片及其制备方法 |
| CN111357858A (zh) * | 2019-09-18 | 2020-07-03 | 广州市好孝心医疗器械有限公司 | 一种具有溶血栓和软化血管功能的复合多肽地龙蛋白压片糖果及其制备方法 |
| CN110680874A (zh) * | 2019-09-25 | 2020-01-14 | 王运权 | 一种治疗心脑血管疾病的中药 |
| CN110679951A (zh) * | 2019-11-13 | 2020-01-14 | 江西沐恩堂生物科技有限公司 | 一种食用地龙蛋白营养产品 |
| CN111418851A (zh) * | 2020-04-29 | 2020-07-17 | 私诺(北京)健康科技有限公司 | 一种血管养护的营养食品 |
| CN112790375A (zh) * | 2020-12-02 | 2021-05-14 | 金口健康管理(潍坊)有限公司 | 一种用于心脑血管疾病的药食同源配方及制备方法 |
| CN115299596A (zh) * | 2021-11-10 | 2022-11-08 | 山东安然纳米实业发展有限公司 | 一种包含人参干细胞的辅助降血脂组合物及其应用 |
| CN117297096A (zh) * | 2023-11-29 | 2023-12-29 | 吉林省特医食品生物科技有限公司 | 一种针对心脑血管的药食同源组合物及制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106858586A (zh) | 一种防治心脑血管疾病的地龙蛋白纳豆人参复合蛋白产品 | |
| CN103393076B (zh) | 一种保健酱油及其制备方法 | |
| CN103330182B (zh) | 一种保健酱油及其制备方法 | |
| CN102511867B (zh) | 红枣阿胶枸杞浓浆及其生产工艺 | |
| CN105039084A (zh) | 一种香蕉复合果酒及其制作方法 | |
| CN108887564A (zh) | 一种硒蛋白杂粮粉配方及其制备方法 | |
| CN103340386A (zh) | 一种保健酱油及其制备方法 | |
| CN104784473A (zh) | 地龙蛋白保健品 | |
| CN102499291B (zh) | 一种具有美容养颜并提高机体免疫功能的奶粉及其制备方法 | |
| CN109198538A (zh) | 一种山楂六物膏的配方及制备方法 | |
| CN106923130A (zh) | 含西红花的固体饮料、其制备方法及应用 | |
| CN101347195B (zh) | 一种复合杂粮营养糊及其制备方法 | |
| CN1114539A (zh) | 强化营养生命米 | |
| CN107201287A (zh) | 一种山楂黄精灵芝茯苓枸杞蜜糖食疗发酵酒 | |
| CN103315269B (zh) | 一种保健酱油及其制备方法 | |
| KR20130065375A (ko) | 한방 빵 제조방법 | |
| CN108771236A (zh) | 一种养生梨膏及其制作方法 | |
| CN103385410A (zh) | 一种樱桃滋补粥及其制备方法 | |
| CN107594278A (zh) | 一种八月瓜复合固体饮料及其制备方法 | |
| CN103478696B (zh) | 一种含银耳清凉滋补食品及其生产方法 | |
| CN102511868A (zh) | 一种添加维生素的红枣阿胶浓浆 | |
| KR101268079B1 (ko) | 한약재와 선옥균을 이용한 식품 첨가제용 조성물 및 그 제조방법 | |
| CN101100681B (zh) | 一种地鳖酶解液及制备方法和应用 | |
| KR20070097386A (ko) | 당귀, 송이버섯을 첨가한 저염 된장 및 그 제조방법 | |
| CN104140921A (zh) | 一种保健醋 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20170620 |
|
| WD01 | Invention patent application deemed withdrawn after publication |